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Abstract 
 
Introduction. The material used for root-end filling has 
to be biocompatible with adjacent periapical tissue and to 
stimulate its regenerative processes. Tricalcium silicate 
cement (TSC), as a new dental material, shows good seal-
ing properties with dentin, high compression strengths 
and better marginal adaptation than commonly used root-
end filling materials. Although optimal postoperative heal-
ing of periapical tissues is mainly influenced by character-
istics of end-root material used, it could sometimes be af-
fected by the influence of systemic diseases, such as diabe-
tes mellitus (DM). Case report. We presented apical heal-
ing of the upper central incisor, retrofilled with TSC, in a 
diabetic patient (type 2 DM) with peripheral neuropathy. 
Standard root-end resection of upper central incisor was 
accompanied by retropreparation using ultrasonic retrotips 
to the depth of 3 mm and retrofilling with TSC. Post-
operatively, the surgical wound healed uneventfully. How-
ever, the patient reported undefined dull pain in the oper-
ated area that could possibly be attributed to undiagnosed 
intraoral diabetic peripheral neuropathy, what was evalu-
ated clinically. Conclusion. Although TSC presents a suit-
able material for apical root-end filling in the treatment of 
chronic periradicular lesions a possible presence of sys-
temic diseases, like type 2 DM, has to be considered in the 
treatment outcome estimation. 
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Apstrakt 
 
Uvod. Materijal koji se koristi za retrogradnu opturaciju ka-
nala korena trebalo bi da bude biokompatibilan sa okolnim 
periapeksnim tkivom i da stimuliše procese njegove regene-
racije. Trikalcijum silikatni cement (TSC), kao novi dentalni 
materijal, pokazuje dobro zaptivanje, visoku kompresivnu 
snagu i bolju ivičnu adaptaciju u odnosu na standardno ko-
rišćene materijale za retroopturaciju. Iako postoperativno 
zarastanje periapikalnog tkiva najviše zavisi od karakteristika 
materijala za retroopturaciju, ponekad na uspeh zarastanja 
može uticati i prisustvo neke sistemske bolesti kao što je di-
jabetes melitus (DM). Prikaz bolesnika. Prikazali smo api-
kalno zarastanje u predelu gornjeg centralnog sekutića, na-
kon retroopturacije sa TSC, kod bolesnika sa DM tipa 2 i 
prisutnom perifernom neuropatijom. Standardna resekcija 
korena gornjeg centralnog sekutića bila je urađena retropre-
paracijom ultrazvučnim nastavcima do dubine od 3 mm i re-
trogradnom opturacijom sa TSC. Zarastanje postoperativne 
regije bilo je u fiziološkim granicama. Bolesnik se, međutim, 
žalio na nedefinisan, tup bol u predelu operisane regije koji 
je verovatno bio povezan sa nedijagnostikovanom intraoral-
nom dijabetičnom perifernom neuropatijom, što je potvr-
đeno kliničkim nalazom. Zaključak. Iako TSC predstavlja 
pogodan materijal za retrogradnu opturaciju kanala korena 
zuba u lečenju hroničnih periradikularnih lezija, u proceni 
ishoda lečenja treba imati u vidu i moguće prisustvo perifer-
nih manfestacija sistemskih bolesti kao što je DM tipa 2. 
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Fig. 1 – Incorrect root canal 11 filling  
and slight apical radiolucency.   
 
 
Fig. 2 – Retropreparation with ultrasonic retrotip. 
 
Introduction 
The primary goal of periradicular surgery is to seal the 
apex of the root canal hermetically, preventing the passage of 
microorganisms or their products into adjacent periapical tis-
sues. Traditionally, root-end filling is obtained by amalgam 
or different types of cement 1. However, modern apical 
surgery is still seeking for the material with superb long-time 
mechanical properties and excellent apical obturation toget-
her with biostimulation of regenerative processes of apical 
tissues 2. Beside the mentioned properties of the material 
used, it has to be biocompatible to the neighbouring periapi-
cal tissues 3. On the other hand, there are still some possible 
complications of periradicular surgery related to disadvanta-
ges of materials used for root-end filling 4, 1.  
Tricalcium silicate cement (TSC), as a new dental mate-
rial, shows mechanical and safety profile which could im-
prove the quality of apical obturation 5, 6. It was also shown 
that TSC possesses good sealing properties with dentin and 
high compression strengths 7, 6. TSC provides better marginal 
adaptation than commonly used root-end filling materials 8. 
Although optimal postoperative healing of periapical 
tissues is mainly influenced by the characteristics of root-end 
material used, it could sometimes be affected by the periph-
eral appearance of systemic diseases 4. Diabetes mellitus 
(DM) results in delayed wound healing and associated com-
plications in dental treatments 9, 10. It was already shown that 
DM decreased osteoblasts function in the rat model 11. In ad-
dition, microvascular changes found in DM may decrease the 
reparatory processes of soft and hard tissue and, gradually, 
could lead to postoperative complications, such as diabetic 
neuropathy 12–15. 
The aim of this report was to present apical healing of 
the upper central incisor, retrofilled with TSC, in a diabetic 
patient with possible peripheral neuropathy, as a complica-
tion associated with type 2 DM. 
Case report 
A 53-year-old man, suffering from type 2 DM, with pe-
ripheral neuropathy and cardiovascular complications (ASA 
III), was referred by his general dental practitioner to the 
Clinic of Oral Surgery, Faculty of Dental Medicine, 
University of Belgrade, for root apical surgery of the right 
central incisor. Clinical examination showed the presence of 
a fistula in the region of the root apex of the tooth. There 
were no signs and symptoms of acute dental infection, altho-
ugh the patient indicated unpleasant discomfort and unmar-
ked chronic pain of the alveolar ridge on the right side. In 
addition, retroalveolar radiogram was done and short canal 
filling with well demarcated slight periapical radiolucency 
were seen around the root apex of tooth (Figure 1). It was 
decided to perform root-end surgery, implying resection of 
the root-end and retrofilling with tricalcium silicate cement 
(TSC) (Biodentine®, Septodont, Saint des Fausses, France) 
under high magnifying glass. 
Standard root resection included sectioning the root-end 
with fissure bar for approximately 2 mm;  retro-preparation 
was done using ultrasonic retro-tips, to the depth of 3 mm 
(Figure 2). TSC was placed in the 3 mm deep retrograde 
cavity of the root-end (Figure 3). After the setting time was 
finished, the wound was debrided and closed primarily. 
One month after the operation, the patient complained to 
constant, undefined, dull pain and discomfort in the operated 
region, which lasted for the next 3 months. Clinical 
examination and control retroalveolar radiogram did not show 
any signs of pathological lesion (Figure 4). There was no fistu-
la in the region of oral mucosa or attached gingiva. Also, there 
were no periodontal pockets around the tooth 11. Regarding 
that, it was necessary to distinguish the possible presence of 
vertical root fracture, which usually cannot be diagnosed 
radiographically. For that reason the re-entry was done. When 
a full-thickness trapezoid mucoperiostal flap was elevated, al-
most complete bone healing in the operated area was present 
(Figure 5). There were no signs of vertical root fracture. At the 
end, the operated area was copiously irrigated with saline and 
interrupted sutures were placed. Follow-up was done 3 and 6 
months and 2 years after re-entry and there were no changes 
both clinically and radiographicaly. During these observation 
periods the mentioned disturbances at the operated region were 
recorded occasionally, with different intensity and usually las-
ted for several weeks.  
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Fig. 3 – Root end filling with tricalcium silicate cement 
(TSC). 
 
 
Fig. 4 – Control retroalveolar radiogram  
3 months after the surgery.  
 
Fig. 5 – Complete bone healing after re-entry. 
 
Discussion 
Different materials have been used for filling root-ends. 
In vitro and in vivo studies have shown that mineral trioxide 
aggregate (MTA), as a gold standard, has considerable seal-
ing ability and better marginal adaptation to dentin 16–18, 
compared to amalgam, super-EBA (ethoxy-benzoic acid) and 
IRM (intermediate restorative material) cement 19. However, 
many drawbacks of MTA, such as difficulties with handling, 
long setting time and high cost, restricts its use as a root-end 
filling material. In addition, it was found that in higher con-
centrations, MTA was toxic to cementoblasts 20. 
Tricalcium silicate-based cement – Biodentine®, was in-
troduced as a bioactive material, with the idea of overcoming 
disadvantages of MTA. Its bioactivity was shown on pulp 
cells by stimulation biomineralisation 21. Likewise, new cal-
cium silicate-based cement induced odontoblast stimulation 
and the production of tertiary dentin in the rat pulp injury 
model 22. Applied directly onto human pulp, TSC induced 
stimulation, biomineralization and odontoblast differentiati-
on 23, 21. It was also shown that TSC induced osteoblast diffe-
rentiation in mesenchimal stem cells 24. When used as root-
end filling material, TSC showed the least microleakage 
compared to other cements 25. TSC-based cement produced 
more prominent Ca2+ and Si2+ uptake into the root canal den-
tine than MTA when used as a root canal obturation material 
in bovine incisors 2. Butt et al. 26 suggested that Biodentine 
possesses better sealing ability, higher compressive strength 
and better handling consistency than MTA. The most recent 
study of Bhavana et al. 27 revealed that TSC had higher anti-
bacterial and antifungal activity than MTA. 
Having in mind all the mentioned advantages and direct 
biological effect of TSC on bone healing, it was expected to 
have a successful surgical result after being used for retrofil-
ling in the presented patient, showing clinical and radiograp-
hic evidence of complete healing. However, the patient re-
ported undefined dull pain in the operated area a month after 
surgery, which lasted for next 3 months. Pain in the operated 
area could possibly be attributed to undiagnosed intraoral di-
abetic peripheral neuropathy, concerning the fact that the pa-
tient suffered from type 2 DM for more than 10 years. It was al-
so documented that signs of intraoral peripheral neuropathy, 
such as the loss of intraoral sensation, hyperesthesia, dysesthesia 
and temporomandibular dysfunction could be related with 
clinically evident peripheral diabetic neuropathy 28. The possib-
le detrimental influence of diabetic neuropathy in progressi-
on of chronic orofacial pain could be also corroborated with 
unpleasant burning mouth syndrome and nonspecific sore-
ness that affect intraoral structures 29. Furthermore, it was 
proposed that prolonged effect of local anaesthetic solution 
could provoke pain in the operating area. Namely, it was 
already shown that the incidence of diabetic neuropathy inc-
reased after spinal and neuraxial block anesthesia 30, 31. Dull 
pain that the patient described could possibly be explained 
by microangiopathy of peripheral dental nerves associated 
with DM and adjunct prolong ischemic effect of vasocons-
trictors from local anaesthetic that was administered in the 
close proximity to peripheral nerves. Atypical facial pain 
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(AFP) could be considered in differential diagnosis, having 
in mind its chronic character. Idiopatic or AFP could be de-
scribed as deep or superficial, poorly localised, and someti-
mes bilateral pain, predominantly in middle-aged and older 
women 32, ,33. On the other hand, dull character of pain locali-
sed only in the operated area, could possibly be attributed to 
peripheral diabetic neuropathy, distinguishing it clinically 
from AFP. 
Conclusion 
Tricalcium silicate cement presents a suitable material 
for apical root-end filling with good mechanical and biologi-
cal properties. However, there are still little data concerning 
long-term results of using TSC as a root-end filling material 
in clinical trials, especially in the risk group of patients such 
as patients with diabetes mellitus, with changed peripheral 
healing capacity. Further long-term clinical studies are nee-
ded to precisely determine clinical and biological behaviour 
of TSC as a root-end filling material and to confirm the di-
rect evidence of regeneration of periapical tissues in humans. 
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